Cachexia at diagnosis is associated with poor survival in head and neck cancer patients

Acta Otolaryngol. 2017 Jul;137(7):778-785. doi: 10.1080/00016489.2016.1277263. Epub 2017 Jan 26.

Abstract

Conclusions: One third of the patients had cachexia with an association of significantly shorter survival. These results suggest that combining HGS and MAMA seems to be a practical method to screen cachexia in patients with head and neck cancer and may also be used when assessing their prognosis.

Objectives: The aim of this study was to analyze the hypothesis that cachexia defined as both low mid-arm muscle area (MAMA) and handgrip strength (HGS) is associated with decreased survival in patients with head and neck squamous cell carcinoma (HNSCC).

Methods: Sixty-five consecutive patients with primary HNSCC were enrolled prior to cancer therapy. Cachexia was defined as low handgrip strength (HGS) and low mid-arm muscle area (MAMA). Nutritional status was assessed by patient-generated subjective global assessment (PG-SGA) and sarcopenia by low MAMA. Biochemical parameters reflecting nutritional status and S-25-OHD were measured.

Results: Cachexia was seen in 31% and sarcopenia in 46% of patients. Altogether, 34% of patients were malnourished. Disease-free survival was 13 months (3-62) in cachectic patients, compared with 66 months (31-78) in non-cachectic patients (p = 0.009). S-25-OHD was 28 nmol/l in cachectic patients, compared with 46 nmol/l in non-cachectic patients (p = 0.009) and prealbumin 187 mg/l and 269 mg/l, respectively (p < 0.001).

Keywords: Nutritional status; anthropometry; handgrip strength; oncology.

MeSH terms

  • Adult
  • Aged
  • Cachexia / etiology*
  • Cachexia / mortality
  • Carcinoma, Squamous Cell / complications*
  • Carcinoma, Squamous Cell / mortality*
  • Cross-Sectional Studies
  • Female
  • Finland / epidemiology
  • Head and Neck Neoplasms / complications*
  • Head and Neck Neoplasms / mortality*
  • Humans
  • Male
  • Middle Aged
  • Prospective Studies